 | • レポートコード：MRC2312MG09377 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のワクチン賦形剤市場規模と予測を収録しています。・世界のワクチン賦形剤市場：売上、2018年-2023年、2024年-2029年 ・世界のワクチン賦形剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のワクチン賦形剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ワクチン安定剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ワクチン賦形剤のグローバル主要企業は、Curia、 Croda Pharma、 Alfa Chemistry、 A & C、 Avantor、 GS、 SEPPIC、 Novavax、 Dynavax Technologies、 Sanofi、 Zhifei Biological、 Escon、 Rico Bio、 CSL Limited、 Creative Biolabs、 Central Drug Houseなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ワクチン賦形剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のワクチン賦形剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のワクチン賦形剤市場：タイプ別市場シェア、2022年 ・ワクチン安定剤、ワクチン乳化剤、ワクチンアジュバント、防腐剤 世界のワクチン賦形剤市場：用途別、2018年-2023年、2024年-2029年 世界のワクチン賦形剤市場：用途別市場シェア、2022年 ・研究、商業 世界のワクチン賦形剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のワクチン賦形剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるワクチン賦形剤のグローバル売上、2018年-2023年 ・主要企業におけるワクチン賦形剤のグローバル売上シェア、2022年 ・主要企業におけるワクチン賦形剤のグローバル販売量、2018年-2023年 ・主要企業におけるワクチン賦形剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Curia、 Croda Pharma、 Alfa Chemistry、 A & C、 Avantor、 GS、 SEPPIC、 Novavax、 Dynavax Technologies、 Sanofi、 Zhifei Biological、 Escon、 Rico Bio、 CSL Limited、 Creative Biolabs、 Central Drug House ************************************************************* ・調査・分析レポートの概要 ワクチン賦形剤市場の定義 市場セグメント 世界のワクチン賦形剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のワクチン賦形剤市場規模 世界のワクチン賦形剤市場規模：2022年 VS 2029年 世界のワクチン賦形剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのワクチン賦形剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のワクチン賦形剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ワクチン安定剤、ワクチン乳化剤、ワクチンアジュバント、防腐剤 ワクチン賦形剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：研究、商業 ワクチン賦形剤の用途別グローバル売上・予測 ・地域別市場分析 地域別ワクチン賦形剤市場規模 2022年と2029年 地域別ワクチン賦形剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Curia、 Croda Pharma、 Alfa Chemistry、 A & C、 Avantor、 GS、 SEPPIC、 Novavax、 Dynavax Technologies、 Sanofi、 Zhifei Biological、 Escon、 Rico Bio、 CSL Limited、 Creative Biolabs、 Central Drug House ... |
This research report provides a comprehensive analysis of the Vaccine Excipients market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vaccine Excipients market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vaccine Excipients, challenges faced by the industry, and potential opportunities for market players.
The global Vaccine Excipients market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vaccine Excipients market presents opportunities for various stakeholders, including Research Applications, Commercial Applications. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vaccine Excipients market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vaccine Excipients market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Vaccine Excipients market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vaccine Excipients market.
Market Overview: The report provides a comprehensive overview of the Vaccine Excipients market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vaccine Stabilizers, Vaccine Emulsifiers), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vaccine Excipients market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vaccine Excipients market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vaccine Excipients market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vaccine Excipients market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vaccine Excipients market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vaccine Excipients market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vaccine Excipients, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vaccine Excipients market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vaccine Excipients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Market segment by Application
Research Applications
Commercial Applications
Global Vaccine Excipients Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccine Excipients, market overview.
Chapter 2: Global Vaccine Excipients market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccine Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccine Excipients capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Vaccine Excipients Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Excipients Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Excipients Overall Market Size
2.1 Global Vaccine Excipients Market Size: 2022 VS 2029
2.2 Global Vaccine Excipients Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vaccine Excipients Sales: 2018-2029
3 Company Landscape
3.1 Top Vaccine Excipients Players in Global Market
3.2 Top Global Vaccine Excipients Companies Ranked by Revenue
3.3 Global Vaccine Excipients Revenue by Companies
3.4 Global Vaccine Excipients Sales by Companies
3.5 Global Vaccine Excipients Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccine Excipients Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccine Excipients Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine Excipients Players in Global Market
3.8.1 List of Global Tier 1 Vaccine Excipients Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine Excipients Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Vaccine Excipients Market Size Markets, 2022 & 2029
4.1.2 Vaccine Stabilizers
4.1.3 Vaccine Emulsifiers
4.1.4 Vaccine Adjuvants
4.1.5 Preservatives
4.2 By Type – Global Vaccine Excipients Revenue & Forecasts
4.2.1 By Type – Global Vaccine Excipients Revenue, 2018-2023
4.2.2 By Type – Global Vaccine Excipients Revenue, 2024-2029
4.2.3 By Type – Global Vaccine Excipients Revenue Market Share, 2018-2029
4.3 By Type – Global Vaccine Excipients Sales & Forecasts
4.3.1 By Type – Global Vaccine Excipients Sales, 2018-2023
4.3.2 By Type – Global Vaccine Excipients Sales, 2024-2029
4.3.3 By Type – Global Vaccine Excipients Sales Market Share, 2018-2029
4.4 By Type – Global Vaccine Excipients Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vaccine Excipients Market Size, 2022 & 2029
5.1.2 Research Applications
5.1.3 Commercial Applications
5.2 By Application – Global Vaccine Excipients Revenue & Forecasts
5.2.1 By Application – Global Vaccine Excipients Revenue, 2018-2023
5.2.2 By Application – Global Vaccine Excipients Revenue, 2024-2029
5.2.3 By Application – Global Vaccine Excipients Revenue Market Share, 2018-2029
5.3 By Application – Global Vaccine Excipients Sales & Forecasts
5.3.1 By Application – Global Vaccine Excipients Sales, 2018-2023
5.3.2 By Application – Global Vaccine Excipients Sales, 2024-2029
5.3.3 By Application – Global Vaccine Excipients Sales Market Share, 2018-2029
5.4 By Application – Global Vaccine Excipients Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Vaccine Excipients Market Size, 2022 & 2029
6.2 By Region – Global Vaccine Excipients Revenue & Forecasts
6.2.1 By Region – Global Vaccine Excipients Revenue, 2018-2023
6.2.2 By Region – Global Vaccine Excipients Revenue, 2024-2029
6.2.3 By Region – Global Vaccine Excipients Revenue Market Share, 2018-2029
6.3 By Region – Global Vaccine Excipients Sales & Forecasts
6.3.1 By Region – Global Vaccine Excipients Sales, 2018-2023
6.3.2 By Region – Global Vaccine Excipients Sales, 2024-2029
6.3.3 By Region – Global Vaccine Excipients Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Vaccine Excipients Revenue, 2018-2029
6.4.2 By Country – North America Vaccine Excipients Sales, 2018-2029
6.4.3 US Vaccine Excipients Market Size, 2018-2029
6.4.4 Canada Vaccine Excipients Market Size, 2018-2029
6.4.5 Mexico Vaccine Excipients Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Vaccine Excipients Revenue, 2018-2029
6.5.2 By Country – Europe Vaccine Excipients Sales, 2018-2029
6.5.3 Germany Vaccine Excipients Market Size, 2018-2029
6.5.4 France Vaccine Excipients Market Size, 2018-2029
6.5.5 U.K. Vaccine Excipients Market Size, 2018-2029
6.5.6 Italy Vaccine Excipients Market Size, 2018-2029
6.5.7 Russia Vaccine Excipients Market Size, 2018-2029
6.5.8 Nordic Countries Vaccine Excipients Market Size, 2018-2029
6.5.9 Benelux Vaccine Excipients Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Vaccine Excipients Revenue, 2018-2029
6.6.2 By Region – Asia Vaccine Excipients Sales, 2018-2029
6.6.3 China Vaccine Excipients Market Size, 2018-2029
6.6.4 Japan Vaccine Excipients Market Size, 2018-2029
6.6.5 South Korea Vaccine Excipients Market Size, 2018-2029
6.6.6 Southeast Asia Vaccine Excipients Market Size, 2018-2029
6.6.7 India Vaccine Excipients Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Vaccine Excipients Revenue, 2018-2029
6.7.2 By Country – South America Vaccine Excipients Sales, 2018-2029
6.7.3 Brazil Vaccine Excipients Market Size, 2018-2029
6.7.4 Argentina Vaccine Excipients Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Vaccine Excipients Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Vaccine Excipients Sales, 2018-2029
6.8.3 Turkey Vaccine Excipients Market Size, 2018-2029
6.8.4 Israel Vaccine Excipients Market Size, 2018-2029
6.8.5 Saudi Arabia Vaccine Excipients Market Size, 2018-2029
6.8.6 UAE Vaccine Excipients Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Curia
7.1.1 Curia Company Summary
7.1.2 Curia Business Overview
7.1.3 Curia Vaccine Excipients Major Product Offerings
7.1.4 Curia Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.1.5 Curia Key News & Latest Developments
7.2 Croda Pharma
7.2.1 Croda Pharma Company Summary
7.2.2 Croda Pharma Business Overview
7.2.3 Croda Pharma Vaccine Excipients Major Product Offerings
7.2.4 Croda Pharma Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.2.5 Croda Pharma Key News & Latest Developments
7.3 Alfa Chemistry
7.3.1 Alfa Chemistry Company Summary
7.3.2 Alfa Chemistry Business Overview
7.3.3 Alfa Chemistry Vaccine Excipients Major Product Offerings
7.3.4 Alfa Chemistry Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.3.5 Alfa Chemistry Key News & Latest Developments
7.4 A & C
7.4.1 A & C Company Summary
7.4.2 A & C Business Overview
7.4.3 A & C Vaccine Excipients Major Product Offerings
7.4.4 A & C Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.4.5 A & C Key News & Latest Developments
7.5 Avantor
7.5.1 Avantor Company Summary
7.5.2 Avantor Business Overview
7.5.3 Avantor Vaccine Excipients Major Product Offerings
7.5.4 Avantor Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.5.5 Avantor Key News & Latest Developments
7.6 GS
7.6.1 GS Company Summary
7.6.2 GS Business Overview
7.6.3 GS Vaccine Excipients Major Product Offerings
7.6.4 GS Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.6.5 GS Key News & Latest Developments
7.7 SEPPIC
7.7.1 SEPPIC Company Summary
7.7.2 SEPPIC Business Overview
7.7.3 SEPPIC Vaccine Excipients Major Product Offerings
7.7.4 SEPPIC Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.7.5 SEPPIC Key News & Latest Developments
7.8 Novavax
7.8.1 Novavax Company Summary
7.8.2 Novavax Business Overview
7.8.3 Novavax Vaccine Excipients Major Product Offerings
7.8.4 Novavax Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.8.5 Novavax Key News & Latest Developments
7.9 Dynavax Technologies
7.9.1 Dynavax Technologies Company Summary
7.9.2 Dynavax Technologies Business Overview
7.9.3 Dynavax Technologies Vaccine Excipients Major Product Offerings
7.9.4 Dynavax Technologies Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.9.5 Dynavax Technologies Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Vaccine Excipients Major Product Offerings
7.10.4 Sanofi Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Zhifei Biological
7.11.1 Zhifei Biological Company Summary
7.11.2 Zhifei Biological Business Overview
7.11.3 Zhifei Biological Vaccine Excipients Major Product Offerings
7.11.4 Zhifei Biological Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.11.5 Zhifei Biological Key News & Latest Developments
7.12 Escon
7.12.1 Escon Company Summary
7.12.2 Escon Business Overview
7.12.3 Escon Vaccine Excipients Major Product Offerings
7.12.4 Escon Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.12.5 Escon Key News & Latest Developments
7.13 Rico Bio
7.13.1 Rico Bio Company Summary
7.13.2 Rico Bio Business Overview
7.13.3 Rico Bio Vaccine Excipients Major Product Offerings
7.13.4 Rico Bio Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.13.5 Rico Bio Key News & Latest Developments
7.14 CSL Limited
7.14.1 CSL Limited Company Summary
7.14.2 CSL Limited Business Overview
7.14.3 CSL Limited Vaccine Excipients Major Product Offerings
7.14.4 CSL Limited Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.14.5 CSL Limited Key News & Latest Developments
7.15 Creative Biolabs
7.15.1 Creative Biolabs Company Summary
7.15.2 Creative Biolabs Business Overview
7.15.3 Creative Biolabs Vaccine Excipients Major Product Offerings
7.15.4 Creative Biolabs Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.15.5 Creative Biolabs Key News & Latest Developments
7.16 Central Drug House
7.16.1 Central Drug House Company Summary
7.16.2 Central Drug House Business Overview
7.16.3 Central Drug House Vaccine Excipients Major Product Offerings
7.16.4 Central Drug House Vaccine Excipients Sales and Revenue in Global (2018-2023)
7.16.5 Central Drug House Key News & Latest Developments
8 Global Vaccine Excipients Production Capacity, Analysis
8.1 Global Vaccine Excipients Production Capacity, 2018-2029
8.2 Vaccine Excipients Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine Excipients Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine Excipients Supply Chain Analysis
10.1 Vaccine Excipients Industry Value Chain
10.2 Vaccine Excipients Upstream Market
10.3 Vaccine Excipients Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine Excipients Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer